The attorneys of Loncar Lyons Jenkins is now accepting cases for women whose vision was irreparably damaged by their use of the medication, pentosan polysulfate, more commonly known by its brand name, Elmiron®.
For individuals diagnosed with maculopathy, also called pigmentary/retinal maculopathy, or retinitis pigmentosa after using Elmiron®, the updated labeling information from June 16, 2020, likely triggers a legal deadline to file suit or the claim will be barred forever.
It is critical that individuals already diagnosed with maculopathy or retinitis pigmentosa have their claims examined by a law firm experienced in pharmaceutical litigation immediately. Time is quickly running out to investigate and file your case.
Elmiron® Is Used to Treat Interstatial Cystitis (IC)
Elmiron® is most commonly prescribed to women who have been diagnosed with interstatial cystitis (“IC”), also referred to as painful bladder syndrome by many physicians. Elmiron® is often prescribed to women who have the symptoms of IC, whether they have actually been diagnosed with the condition or not.
The syndrome is characterized by pain and pressure in the bladder area resulting in urgency, frequency, even painful intercourse. A urologist we work with describes it as “a UTI without an infection.”
There is no cure for IC but Elmiron® was approved for use by the FDA in September of 1996 and has been prescribed to alleviate the symptoms by allegedly preventing inflammation and irritation of the bladder walls.
Because Elmiron® only treats the symptoms of painful bladder syndrome, most patients use the medication for extended periods of time.
The Link Between Elmiron® and Irreversible Vision Damage
Independent studies began revealing a troublesome link between Elmiron and irreversible vision damage in long-term users as far back as 2015. It is likely the manufacturers knew or should have known about the links to permanent vision damage – a statistical analysis of vision claims among Elmiron® users in California’s Kaiser Permanente system suggests as many as 1 in 4 long-terms users may have suffered a retinal injury.
In June of 2020, the labeling information was quietly revised to warn of possible permanent vision damage as a result of long-term use. Your prescriber may not have told you of the revised labeling information because they were not aware of the change. For many victims, the warning was simply too late.
Due to the manufacturer’s failure to properly label Elmiron® it is likely many victims were incorrectly diagnosed with pattern dystrophy or macular degeneration.
Signs You May Have Retina Damage
If you used Elmiron® for three years or more and are experiencing significant vision problems, it is important to have your retinas examined immediately. If you are under the care of an ophthalmologist or retina specialist, it is critical that you notify them of your long-term exposure to Elmiron®. Treatment options are available, but it is critical to initiate proper medical care as soon as possible.
Symptoms of retina damage may include:
- blurred vision
- distorted vision
- difficulty adjusting to light or darkness
- dark or blank spots towards the center of vision
- straight lines appearing curved or squiggly
- muted, less vivid colors
- complete vision loss
If you experienced any of these symptoms after taking Elmiron®, you may have a personal injury claim.
Get Your Free Consultation with a Dangerous Drug Attorney
The attorneys at Loncar Lyon Jenkins have been successfully litigating cases nationwide since 1999 for those injured by dangerous drugs. We work on a contingency-fee-basis meaning we are owed no fees or expenses unless we successfully settle your case or collect on a verdict.
If you or a loved one were diagnosed with maculopathy, retinitis pigmentosa, macular degeneration, or pattern dystrophy after using Elmiron for three or more years, complete the contact form or call us at (800) 285-4878 for a free, no-obligation consultation.